Search Login Register

JNK Mitogen-Activated Protein Kinases Summary

Description: A subgroup of mitogen-activated protein kinases that activate TRANSCRIPTION FACTOR AP-1 via the phosphorylation of C-JUN PROTEINS. They are components of intracellular signaling pathways that regulate CELL PROLIFERATION; APOPTOSIS; and CELL DIFFERENTIATION.

Also Known As: c-jun Amino-Terminal Kinase; c-jun N-Terminal Kinase; jun-NH2-Terminal Kinase; jun-NH2-Terminal Kinases; Amino-Terminal Kinase, c-jun Show All >>

Networked: 1056 relevant articles (15 outcomes, 94 trials/studies) for this Bio-Agent

Key Diseases for which JNK Mitogen-Activated Protein Kinases is Relevant

  1. Insulin Resistance : 4 outcomes 1 study in 71 results
  2. Brain Injuries (Brain Injury) : 2 outcomes 6 studies in 18 results
  3. Ischemia : 1 outcome 4 studies in 44 results
  4. Reperfusion Injury : 1 outcome 3 studies in 15 results
  5. Pancreatitis : 1 outcome 2 studies in 6 results
Show All >>

Drugs Related to JNK Mitogen-Activated Protein Kinases

  1. Phosphotransferases (Kinase)
  2. Glucose (Dextrose)
  3. Protein Kinases (Protein Kinase)
  4. anthra(1,9-cd)pyrazol-6(2H)-one
  5. Reactive Oxygen Species (Oxygen Radicals)
  6. Insulin (Novolin)
  7. Mitogen-Activated Protein Kinase 3
  8. Caerulein (Ceruletide)
  9. Messenger RNA (mRNA)
  10. Serine (L-Serine)
Show All >>

Therapies Related to JNK Mitogen-Activated Protein Kinases

  1. Ligation
  2. Resuscitation
  3. Drug Therapy (Chemotherapy)
  4. Lasers (Laser)
  5. Intraperitoneal Injections
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.